SARS-CoV-2 targets MAVS for immune evasion

Alessia Zotta; Alexander Hooftman; Luke O'neill

doi:10.1038/s41556-021-00712-y

Article2023

PO04 SARS-CoV-2 Vaccinations and Risk of Venous Thrombosis - Case Control Study

Willian van Dijk, Aydın Kant, Frits R. Rosendaal, Astrid van Hylckama Vlieg

Research and Practice in Thrombosis and Haemostasis

Article2023

PB0088 Alterations in Thrombin Generation after SARS-CoV-2 Vaccination and the Relation with Inflammation

Willian van Dijk, Maria Prins, Astrid van Hylckama Vlieg, Leo G. Visser, Frits R. Rosendaal

Research and Practice in Thrombosis and Haemostasis

Article2003

Spotlight on new anti-inflammatory drug targets in the immune system

Stephen G. Ward, Luke O'neill

Current Opinion in Immunology

Preprint2020

Human airway organoids model SARS-CoV-2 high infectiousness and evasion of interferon response

Jie Zhou, Man Chun Chiu, Cun Li, Xiaojuan Liu, Xiaoyu Zhao, Dong Wang, Yuxuan Wei, Hin Chu, Jian‐Piao Cai, Cyril Chik-Yan Yip, Vincent Kwok‐Man Poon, Ivy Chan, Kenneth Kak‐Yuen Wong, Jasper Fuk-Woo Chan, Zhiwei Chen, Honglin Chen, Hans Clevers, Kwok‐Yung Yuen

Editorial Material2012

Spurs in the hunt for new immunomodulatory drug targets

Stephen G. Ward, Luke O'neill

Current Opinion in Pharmacology

SARS-CoV-2 targets MAVS for immune evasion

Abstract

Discussion(0)

Related publications

PO04 SARS-CoV-2 Vaccinations and Risk of Venous Thrombosis - Case Control Study

PB0088 Alterations in Thrombin Generation after SARS-CoV-2 Vaccination and the Relation with Inflammation

Spotlight on new anti-inflammatory drug targets in the immune system

Human airway organoids model SARS-CoV-2 high infectiousness and evasion of interferon response

Spurs in the hunt for new immunomodulatory drug targets